Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Am J Transplant. 2016 Jun 15;16(8):2377–2383. doi: 10.1111/ajt.13847

Table 3.

Modification of the effect of recipient HIV status on likelihood of graft loss by recipient and donor characteristics (adjusted)

RECIPIENT FACTORS HIV+ HIV− HR within strata

N with/without graft loss N with/without graft loss
HR (95% CI) HR (95% CI)
 HCV− A 102/272 1.21 (0.92, 1.60) 22,222/53,267 Ref 1.21 (0.92, 1.60)
 HCV+ 69/65 2.72 (1.75, 4.22) 1,950/2,742 1.33 (1.26, 1.41) 2.04 (1.32, 3.16)
 HCV+*HIV+ 1.68 (1.19, 2.36) P=0.003

 AP 0.43 (0.23, 0.63) RERI 1.17 (0.15, 2.19) p=0.02

 HLA mismatch ≤3 A 27/81 0.91 (0.58, 1.43) 7,021/17,444 Ref 0.91 (0.58, 1.43)
 HLA mismatch >3 151/267 1.80 (1.31, 2.47) 17,900/39,871 1.13 (1.10, 1.17) 1.59 (1.15, 2.19)
 HIV+*HLA>3 1.74 (1.15, 2.65)

 AP 0.42 (0.24, 0.60) RERI 0.75 (0.22, 1.28) p=0.01

DONOR FACTORS
 Age < 50B 128/266 1.64 (1.20, 2.24) 14,471/42,041 Ref 1.64 (1.20, 2.24)
 Age ≥ 50 50/82 1.66 (1.07, 2.57) 9,450/15,274 1.50 (1.45, 1.55) 1.11 (0.72, 1.70)
 HIV+*Age≥ 50 0.68 (0.49, 0.94)

 AP −0.29 (−0.71, 0.14) RERI −0.48 (−1.02, 0.07) p=0.09

 Non-AAB 153/292 1.52 (1.13, 2.05) 21,032/49,513 Ref 1.52 (1.13, 2.05)
 African-American 25/56 1.36 (0.74, 2.53) 3,889/7,802 1.20 (1.13, 2.14) 1.14 (0.62, 2.11)
 HIV+*AA Race 0.75 (0.47, 1.19)

 AP −0.26 (−0.88, 0.36) RERI −0.35 (−0.98, 0.27) p=0.27

 KDPI < 85 A 186/459 1.46 (1.11, 1.91) 30,545/92,514 Ref 1.46 (1.11, 1.91)
 KDPI ≥85 32/26 2.31 (1.12, 4.76) 4,369/5,345 1.65 (1.58, 1.73) 1.40 (0.68, 2.86)
HIV+*KDPI≥85 0.96 (0.53, 1.72)

 AP 0.08 (−0.48, 0.65) RERI 0.20 (−1.25, 1.64) p=0.79

 CIT <12 hrs A 67/200 1.31 (0.93, 1.84) 46,163/12,330 Ref 1.31 (0.93, 1.84)
 CIT≥12 hrs 134/256 1.64 (1.12, 2.41) 18,300/41,162 1.10 (1.06, 1.16) 1.49 (1.01, 2.18)
HIV+*CIT≥12 1.14 (0.70, 1.84)

 AP 0.14 (−0.23, 0.51) RERI 0.23 (−0.50, 0.96) p=0.54
A

adjusted for recipient age, race, HCV status, HLA mismatches, PRA, diabetes, CIT, and KDPI

B

adjusted for recipient age, race, HCV status, HLA mismatches, PRA, diabetes, donor age, and donor race

AA, African-American; AP, attributable proportion; CIT, cold ischemia time; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HLA, human leukocyte antigen; HR, hazard ratio; KDPI, Kidney Donor Profile Index; PRA, panel-reactive antibody; RERI, relative excess risk due to interaction.